Alumis to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

GlobeNewswireNov 4 21:00

Alumis Initiated at Outperform by Baird

Dow JonesOct 31 18:08 · Ratings

Baird Initiates Alumis(ALMS.US) With Buy Rating, Announces Target Price $25

Futu NewsOct 31 05:32 · Ratings

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside

BenzingaOct 18 02:32

This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaOct 17 21:05

Express News | Alumis Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $30

BreakingsOct 17 18:05